← back to search

Jiaojiao Yu

Kunming University of Science and Technology · CN
🔎 Find collaborators in Cell Biology · Epidemiology →
Search 5.9M scientists by topic, h-index, country & funding — free.
Area of research
Cell Biology · Epidemiology
Research interest
Research focused on Cancer research and Epidermal growth factor receptor, with related work in Arsenic trioxide, Steatohepatitis, Proinflammatory cytokine. Notable publications include 'TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target', 'TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence', and 'CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis'.
h-index
citations
323
works
6
NIH funding
primary concept
email

Recent publications

Minimally invasive upconversion optogenetics for Parkinson's disease treatment
Biomaterials 2025cited by 3position: middledoi
A Non‐Metallic Nanozyme Ameliorates Pulmonary Hypertension Through Inhibiting ROS/TGF‐β1 Signaling
Advanced Healthcare Materials 2024cited by 14position: middledoi
Abstract 1656: ISM6331, a novel and potent pan-TEAD inhibitor, exhibits strong anti-tumor activity in preclinical models of Hippo pathway-dysregulated cancers
Cancer Research 2024cited by 10position: middledoi
A mechanism linking ferroptosis and ferritinophagy in melatonin-related improvement of diabetic brain injury
iScience 2024cited by 10position: firstdoi
CD1d protects against hepatocyte apoptosis in non-alcoholic steatohepatitis
Journal of Hepatology 2023cited by 45position: middledoi
Differentially expressed tRNA-derived fragments and their roles in primary cardiomyocytes stimulated by high glucose
Frontiers in Endocrinology 2023cited by 38position: middledoi
TRIB3-EGFR interaction promotes lung cancer progression and defines a therapeutic target
Nature Communications 2020cited by 112position: firstdoi
TRIB3 Promotes APL Progression through Stabilization of the Oncoprotein PML-RARα and Inhibition of p53-Mediated Senescence
Cancer Cell 2017cited by 108position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Bing Cui · Jiangsu University2 papers (2017–2020)Shao‐Kai Sun · China Pharmaceutical University2 papers (2024–2025) · 2 papers (2024–2025)Ke Li · Jinan University2 papers (2017–2020)Xiaowei Zhang · Central South University2 papers (2017–2020)Shanshan Liu · Nanjing University of Chinese Medicine2 papers (2017–2020)Bo Huang · Zhejiang Sci-Tech University2 papers (2017–2020) · 2 papers (2017–2020)Shuang Shang · Chinese Academy of Medical Sciences & Peking Union Medical College2 papers (2017–2020)Fang Hua · Wuhan University2 papers (2017–2020)Jinmei Yu · Union Hospital2 papers (2017–2020)Supriya Bavadekar · New York University1 papers (2024–2024)Shouguo Liu · Nanjing Medical University1 papers (2023–2023)Hui Che · Harbin Medical University1 papers (2023–2023)Yongting Zhao · Harbin Medical University1 papers (2023–2023)Chuan Su · China Pharmaceutical University1 papers (2023–2023)Tingting Zhang · Shihezi University1 papers (2017–2017)Man Zhang · University of California, Davis1 papers (2024–2024)Jinxin Liu · Weifang Medical University1 papers (2024–2024)Ling Wang · University of Iowa1 papers (2024–2024)
Looking for a research collaborator?
Search millions of scientists by field, institution, impact, and funding status — see their work, find their email, and reach out directly.
Find collaborators in Cell Biology · Epidemiology →